IRESSA (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the IRESSA drug offered from AstraZeneca Pharmaceuticals LP. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
| NON-PROPRIETARY NAME: | Gefitinib |
| SUBSTANCE NAME: | GEFITINIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-07-13 |
| END MARKETING DATE: | 0000-00-00 |
IRESSA HUMAN PRESCRIPTION DRUG Details:
| Item Description | IRESSA from AstraZeneca Pharmaceuticals LP |
| LABELER NAME: | AstraZeneca Pharmaceuticals LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/1) |
| START MARKETING DATE: | 2015-07-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0310-0482_a2e9ea1a-f971-4c2b-addf-6791af0041e2 |
| PRODUCT NDC: | 0310-0482 |
| APPLICATION NUMBER: | NDA206995 |
Other GEFITINIB Pharmaceutical Manufacturers / Labelers:
